Eversept Partners LP Purchases New Shares in IVERIC bio, Inc. (NASDAQ:ISEE)

Eversept Partners LP purchased a new stake in shares of IVERIC bio, Inc. (NASDAQ:ISEE – Get Rating) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 350,747 shares of the company’s stock, valued at approximately $7,509,000. Eversept Partners LP owned 0.29% […]

Related Keywords

Keith Westby ,Robertw Baird ,David Francis Carroll ,Company Profile ,Securities Exchange Commission ,Hightower Advisors ,Credit Suisse Group ,Jpmorgan Chase Co ,Nasdaq ,Alphacrest Capital Management ,York Mellon Corp ,Metlife Investment Management ,Eversept Partners ,Get Rating ,New York Mellon Corp ,Tower Advisors ,Crest Capital Management ,Life Investment Management ,Suisse Group ,Francis Carroll ,Exchange Commission ,Iveric Bio ,Nasdaq Isee ,Isee ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,